Catalysts for Strides Pharma Inc
359 tracked
Nov 21, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
MEPERIDINE HYDROCHLORIDE — FDA approval
MEPERIDINE HYDROCHLORIDE
→
Oct 31, 2024
approval
ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Oct 31, 2024
approval
ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
MORPHINE SULFATE — FDA approval
Kapanol
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 9, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Oct 3, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Oct 3, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Oct 3, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Aug 26, 2024
approval
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 13, 2024
approval
MYCOPHENOLATE MOFETIL — FDA approval
MYCOPHENOLATE MOFETIL
→
Jul 15, 2024
approval
MEPERIDINE HYDROCHLORIDE — FDA approval
MEPERIDINE HYDROCHLORIDE
→
May 1, 2024
approval
MYCOPHENOLATE MOFETIL — FDA approval
MYCOPHENOLATE MOFETIL
→
Dec 21, 2023
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→